Skip to main content
. 2020 Nov 24;6:87. doi: 10.1038/s41421-020-00211-8

Fig. 7. LncLy6C promotes enrichment of C/EBPβ and H3K4me3 on the promoter region of Nr4A1.

Fig. 7

a Map of H3K4me3 marks, C/EBPβ binding sites, P1 and P2 sites of CHIP-PCR on the promoter region of Nr4A1. b CHIP-PCR in BMDM of wt and LncLy6C KO (LNC KO), control BMDM (NC), and butyrate-treated BMDMs (butyrate). % input was compared. Iso isotypic antibody. c QRT-PCR of Nr4A1 in BMDM of wt and LncLy6C KO (LNC KO) (left) or control BMDM (NC) and butyrate-treated BMDMs (Buty) (right). d Immunoblotting of Nr4A1 in BMDM of wt and LncLy6C KO (LNC KO) or control BMDM (NC) and butyrate-treated BMDMs (butyrate). e Immunoblotting of Nr4A1 in the BMDM of wt and LncLy6C KO (LNC KO) after exposed to different concentration of butyrate. f Map of butyrate-mediated lncLy6C to regulate the expression of Nr4A1. Butyrate-induced LncLy6C may promote the expression of Nr4A1 through binding with C/EBP and lysine methyltransferases of H3K4me3. One-way ANOVA and Bonferroni’s multiple comparison test in b. Two-sided Student’s t test in c.